KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)R&D In ProcessReceivables - NetShares Issued
Ratios

AbbVie (ABBV) Receivables - Net (2016 - 2025)

AbbVie (ABBV) has disclosed Receivables - Net for 14 consecutive years, with $12.6 billion as the latest value for Q4 2025.

  • Quarterly Receivables - Net rose 15.29% to $12.6 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $12.6 billion through Dec 2025, up 15.29% year-over-year, with the annual reading at $12.6 billion for FY2025, 15.29% up from the prior year.
  • Receivables - Net for Q4 2025 was $12.6 billion at AbbVie, down from $12.8 billion in the prior quarter.
  • The five-year high for Receivables - Net was $12.8 billion in Q3 2025, with the low at $9.3 billion in Q3 2021.
  • Average Receivables - Net over 5 years is $11.2 billion, with a median of $11.3 billion recorded in 2022.
  • The sharpest move saw Receivables - Net skyrocketed 50.71% in 2021, then fell 2.12% in 2024.
  • Over 5 years, Receivables - Net stood at $10.0 billion in 2021, then grew by 12.8% to $11.3 billion in 2022, then decreased by 0.88% to $11.2 billion in 2023, then decreased by 2.12% to $10.9 billion in 2024, then increased by 15.29% to $12.6 billion in 2025.
  • According to Business Quant data, Receivables - Net over the past three periods came in at $12.6 billion, $12.8 billion, and $12.6 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.